Outlook Therapeutics (OTLK) Change in Cash (2015 - 2026)
Outlook Therapeutics (OTLK) reported Change in Cash of -$929198.0 for Q1 2026, down 150.13% year-over-year from $1.9 million in Q1 2025, and down 256.34% quarter-over-quarter from $594339.0 in Q4 2025.
Outlook Therapeutics (OTLK) Change in Cash (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 12 years of Change in Cash data on file, last reported at -$929198.0 in Q1 2026.
- Change in Cash for Q1 2026 came in at -$929198.0, down 150.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $191913.0 (up 100.48% YoY), and the FY2025 annual result was -$6.8 million, up 19.14% from the prior year.
- Change in Cash eased to -$929198.0 in Q1 2026 per OTLK's latest filing, from $594339.0 in the prior quarter.
- Over five years, Change in Cash peaked at $36.9 million in Q1 2024 and troughed at -$32.4 million in Q2 2022.
- A 5-year average of -$3.7 million and a median of -$8.7 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2026: Change in Cash jumped 523.25% in 2024, then tumbled 150.13% in 2026.
- A 5-year view of Change in Cash shows it stood at $34.9 million in 2022, then slumped by 137.3% to -$13.0 million in 2023, then grew by 29.23% to -$9.2 million in 2024, then jumped by 106.44% to $594339.0 in 2025, then slumped by 256.34% to -$929198.0 in 2026.
- Business Quant data shows OTLK's Change in Cash at -$929198.0 in Q1 2026, $594339.0 in Q4 2025, and -$817729.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -45.97 Mn |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | -929,198.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -929,198.00 |
| Dec 31, 2025 | 594,339.00 |
| Sep 30, 2025 | -817,729.00 |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | -9.22 Mn |
| Sep 30, 2024 | -17.10 Mn |
| Jun 30, 2024 | -15.20 Mn |
| Mar 31, 2024 | 36.87 Mn |
| Dec 31, 2023 | -13.04 Mn |
| Sep 30, 2023 | -10.32 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Mar 31, 2023 | -8.71 Mn |
| Dec 31, 2022 | 34.94 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -32.40 Mn |
| Mar 31, 2022 | -11.73 Mn |
| Dec 31, 2021 | 55.67 Mn |
| Sep 30, 2021 | -5.21 Mn |
| Jun 30, 2021 | -17.48 Mn |